recipharm advanced bio
PrivateLast Round
Take Private
Feb 15, 2021
Last Round Size
$2.28B
Est. Valuation
$3B
Total Funding Raised
$2.82B
Company Overview
A contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products (ATMPs).
Historical Pricing
Historical view of private secondary pricing and transaction trends.
recipharm advanced bio Comparables
Compare recipharm advanced bio with similar companies based on industry and business-model similarity.
No public comparables are available for recipharm advanced bio. Request access to learn about comparables coverage.
Book a demoFor institutional investors. Book with your work email.
recipharm advanced bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Take Private | Feb 15, 2021 | ||||
| Follow-on Offering | May 27, 2020 | ||||
| Follow-on Offering | May 19, 2016 | ||||
| IPO | Apr 3, 2014 | ||||
| Buyout/LBO | Mar 1, 1995 |
For institutional investors. Book with your work email.
recipharm advanced bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.